Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Chemico-Biological Interactions|February 20, 2010
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidatesPelayo Camps, Xavier Formosa, Carles Galdeano, et al.
ACS Central Science|April 28, 2025
A Multicomponent Reaction-Based Platform Opens New Avenues in Aryl Hydrocarbon Receptor ModulationPau Nadal Rodríguez, Frederick Hartung, Marina Pedrola, et al.
Journal of Medicinal Chemistry|July 25, 2020
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6F Javier Pérez-Areales, María Garrido, Ester Aso, et al.
Journal of Medicinal Chemistry|December 22, 2011
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseasesCarles Galdeano, Elisabet Viayna, Irene Sola, et al.
Communications Chemistry|August 1, 2025
A bottom-up approach to find lead compounds in expansive chemical spacesÁlvaro Serrano-Morrás, Andrea Bertran-Mostazo, Marina Miñarro-Lleonar, et al.
Journal of Medicinal Chemistry|March 10, 2020
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's DiseaseSònia Abás, Sergio Rodríguez-Arévalo, Andrea Bagán, et al.
Molecules (Basel, Switzerland)|January 4, 2019
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4Arduino A Mangoni, Catherine Guillou, Jean Jacques Vanden Eynde, et al.
Pageof 28